Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia. (Q37809009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yung-Li Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shiann-Tarng Jou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Hsiu-Hao Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yu-Mei Liao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Pei-Chin Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Dong-Tsamn Lin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Shyh-Shin Chiou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Kai-Hsin Lin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Tai-Tsung Chang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

published in

Pediatric Blood & Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

420-424

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21072825%20AND%20SRC:MED&resulttype=core&format=json

Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

16 January 2020

cites work

1 reference

Deferasirox (Exjade) for the treatment of iron overload

21 January 2018

1 reference

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

21 January 2018

1 reference

Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload

21 January 2018

1 reference

Deferasirox pharmacokinetics in patients with adequate versus inadequate response

21 January 2018

1 reference

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

21 January 2018

1 reference

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

21 January 2018

1 reference